Market Closed -
NSE India S.E.
07:43:47 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
1,079
INR
|
-0.09%
|
|
+5.16%
|
+26.39%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
182,619
|
58,084
|
131,124
|
124,718
|
131,124
|
304,580
|
-
|
-
|
Enterprise Value (EV)
1 |
212,024
|
91,837
|
162,310
|
150,223
|
162,699
|
324,424
|
301,500
|
293,275
|
P/E ratio
|
20.5
x
|
7.49
x
|
13.5
x
|
13.2
x
|
44.1
x
|
42.6
x
|
25
x
|
19.2
x
|
Yield
|
0.31%
|
1.21%
|
0.54%
|
0.57%
|
0.54%
|
0.21%
|
0.26%
|
0.29%
|
Capitalization / Revenue
|
1.85
x
|
0.55
x
|
1.2
x
|
1.01
x
|
1.01
x
|
2.51
x
|
2.17
x
|
1.95
x
|
EV / Revenue
|
2.15
x
|
0.86
x
|
1.48
x
|
1.22
x
|
1.25
x
|
2.67
x
|
2.15
x
|
1.88
x
|
EV / EBITDA
|
11.8
x
|
5.41
x
|
7.79
x
|
6.47
x
|
7.14
x
|
25.2
x
|
12.5
x
|
10.1
x
|
EV / FCF
|
244
x
|
19.9
x
|
45.5
x
|
47.2
x
|
923
x
|
16.1
x
|
46.6
x
|
30.8
x
|
FCF Yield
|
0.41%
|
5.02%
|
2.2%
|
2.12%
|
0.11%
|
6.2%
|
2.15%
|
3.24%
|
Price to Book
|
3.05
x
|
0.96
x
|
1.86
x
|
1.37
x
|
1.38
x
|
2.88
x
|
2.55
x
|
2.27
x
|
Nbr of stocks (in thousands)
|
282,168
|
282,168
|
282,168
|
282,168
|
282,168
|
282,188
|
-
|
-
|
Reference price
2 |
647.2
|
205.8
|
464.7
|
442.0
|
464.7
|
1,079
|
1,079
|
1,079
|
Announcement Date
|
5/29/19
|
6/26/20
|
5/28/21
|
5/27/22
|
5/19/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
98,655
|
106,410
|
109,439
|
123,409
|
129,901
|
121,436
|
140,342
|
156,218
|
EBITDA
1 |
17,939
|
16,981
|
20,844
|
23,203
|
22,784
|
12,869
|
24,151
|
28,995
|
EBIT
1 |
14,254
|
12,809
|
16,408
|
18,336
|
16,671
|
7,400
|
18,277
|
22,373
|
Operating Margin
|
14.45%
|
12.04%
|
14.99%
|
14.86%
|
12.83%
|
6.09%
|
13.02%
|
14.32%
|
Earnings before Tax (EBT)
1 |
12,580
|
10,961
|
13,825
|
14,412
|
8,685
|
-206.1
|
18,250
|
23,369
|
Net income
1 |
8,917
|
7,760
|
9,701
|
9,936
|
2,972
|
33,363
|
11,127
|
14,861
|
Net margin
|
9.04%
|
7.29%
|
8.86%
|
8.05%
|
2.29%
|
27.47%
|
7.93%
|
9.51%
|
EPS
2 |
31.60
|
27.50
|
34.38
|
33.40
|
10.53
|
25.35
|
43.10
|
56.30
|
Free Cash Flow
1 |
870
|
4,610
|
3,565
|
3,185
|
176.3
|
20,118
|
6,472
|
9,512
|
FCF margin
|
0.88%
|
4.33%
|
3.26%
|
2.58%
|
0.14%
|
16.57%
|
4.61%
|
6.09%
|
FCF Conversion (EBITDA)
|
4.85%
|
27.15%
|
17.1%
|
13.73%
|
0.77%
|
156.33%
|
26.8%
|
32.81%
|
FCF Conversion (Net income)
|
9.76%
|
59.41%
|
36.74%
|
32.06%
|
5.93%
|
60.3%
|
58.17%
|
64.01%
|
Dividend per Share
2 |
2.000
|
2.500
|
2.500
|
2.500
|
2.500
|
2.318
|
2.830
|
3.168
|
Announcement Date
|
5/29/19
|
6/26/20
|
5/28/21
|
5/27/22
|
5/19/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
27,868
|
28,599
|
29,649
|
31,474
|
31,734
|
30,191
|
27,773
|
33,752
|
34,639
|
33,737
|
34,016
|
35,822
|
34,919
|
33,001
|
EBITDA
1 |
5,301
|
5,234
|
5,736
|
5,902
|
5,148
|
4,634
|
4,726
|
6,216
|
6,202
|
6,050
|
5,866
|
6,716
|
5,905
|
5,152
|
EBIT
1 |
4,149
|
4,124
|
4,605
|
4,670
|
3,958
|
3,319
|
4,108
|
4,659
|
4,580
|
4,584
|
4,320
|
5,137
|
3,989
|
3,075
|
Operating Margin
|
14.89%
|
14.42%
|
15.53%
|
14.84%
|
12.47%
|
10.99%
|
14.79%
|
13.8%
|
13.22%
|
13.59%
|
12.7%
|
14.34%
|
11.42%
|
9.32%
|
Earnings before Tax (EBT)
1 |
3,480
|
3,375
|
4,436
|
3,850
|
3,430
|
2,697
|
4,080
|
4,802
|
4,710
|
-4,908
|
3,334
|
3,204
|
4,099
|
2,164
|
Net income
1 |
2,482
|
2,339
|
3,065
|
2,577
|
2,219
|
1,726
|
1,925
|
2,604
|
2,726
|
-4,283
|
1,499
|
2,574
|
2,450
|
2,243
|
Net margin
|
8.91%
|
8.18%
|
10.34%
|
8.19%
|
6.99%
|
5.72%
|
6.93%
|
7.72%
|
7.87%
|
-12.7%
|
4.41%
|
7.19%
|
7.02%
|
6.8%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/12/21
|
5/28/21
|
8/13/21
|
11/12/21
|
2/11/22
|
5/27/22
|
8/10/22
|
11/11/22
|
2/10/23
|
5/19/23
|
8/11/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
29,405
|
33,753
|
31,187
|
25,505
|
31,575
|
19,844
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
3,080
|
11,304
|
Leverage (Debt/EBITDA)
|
1.639
x
|
1.988
x
|
1.496
x
|
1.099
x
|
1.386
x
|
1.542
x
|
-
|
-
|
Free Cash Flow
1 |
870
|
4,610
|
3,565
|
3,185
|
176
|
20,118
|
6,472
|
9,512
|
ROE (net income / shareholders' equity)
|
15.4%
|
12.9%
|
14.3%
|
12.3%
|
6.79%
|
1.45%
|
10.5%
|
12%
|
ROA (Net income/ Total Assets)
|
6.68%
|
5.38%
|
6.2%
|
6.08%
|
-
|
-
|
-
|
-
|
Assets
1 |
133,500
|
144,227
|
156,483
|
163,434
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
212.0
|
215.0
|
250.0
|
322.0
|
336.0
|
374.0
|
423.0
|
474.0
|
Cash Flow per Share
2 |
46.90
|
49.30
|
40.10
|
39.30
|
22.20
|
63.90
|
33.40
|
41.20
|
Capex
1 |
12,372
|
9,314
|
7,748
|
7,901
|
6,078
|
6,667
|
7,000
|
7,333
|
Capex / Sales
|
12.54%
|
8.75%
|
7.08%
|
6.4%
|
4.68%
|
5.49%
|
4.99%
|
4.69%
|
Announcement Date
|
5/29/19
|
6/26/20
|
5/28/21
|
5/27/22
|
5/19/23
|
-
|
-
|
-
|
Last Close Price
1,079
INR Average target price
962.8
INR Spread / Average Target -10.80% Consensus |
1st Jan change
|
Capi.
|
---|
| +26.39% | 3.65B | | +19.62% | 43.34B | | +20.44% | 21.96B | | +10.86% | 14.09B | | +13.07% | 13.64B | | +37.46% | 11.43B | | -8.59% | 6.86B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +8.46% | 5.22B |
Generic Pharmaceuticals
|